anti-Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) Antikörper

The uptake of nucleosides by transporters, such as SLC29A2, is essential for nucleotide synthesis by salvage pathways in cells that lack de novo biosynthetic pathways. Zusätzlich bieten wir Ihnen SLC29A2 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
SLC29A2 3177 Q14542
SLC29A2 13340 Q61672
SLC29A2 65194 O54699
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-SLC29A2 Antikörper auf antikoerper-online.de

Showing 10 out of 44 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB Host: Rabbit Target Name: SLC29A2 Sample Tissue: Human Ovary Tumor Antibody Dilution: 1.0ug/ml Host: Rabbit Target Name: SLC29A2 Sample Type: Human Fetal Liver Antibody Dilution: 1.0ug/ml 100 μL 2 bis 3 Tage
$289.00
Details
Human Kaninchen Unkonjugiert IHC, WB Human kidney 100 μL 2 bis 3 Tage
$249.00
Details
Rind (Kuh) Kaninchen Unkonjugiert WB Western blot analysis of ENT2 expression in HEK293T (A), Raw264.7 (B) whole cell lysates. 200 μL 13 bis 14 Tage
$487.50
Details
Human Kaninchen Unkonjugiert IHC, IHC (p), WB 100 μL 11 bis 14 Tage
$507.83
Details
Pferd Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Human Kaninchen Unkonjugiert WB Mouse heart lysates probed with Rabbit Anti-ENT2 Polyclonal Antibody, Unconjugated (ABIN2559658) at 1:300 in 4˚C. Followed by conjugation to secondary antibody at 1:5000 for 90min at 37˚C. Formalin-fixed and paraffin embedded human laryngeal tissue labeled with Rabbit Anti-ENT2 Polyclonal Antibody, Unconjugated (ABIN2559658) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL 3 bis 7 Tage
$317.90
Details
Human Kaninchen Unkonjugiert ELISA, IHC, IHC (p), WB Human Skeletal Muscle: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg 11 bis 14 Tage
$616.00
Details
Human Maus Unkonjugiert IF, WB Western Blot analysis of SLC29A2 expression in transfected 293T cell line by SLC29A2 MaxPab polyclonal antibody.Lane 1: SLC29A2 transfected lysate(50.16 KDa).Lane 2: Non-transfected lysate. Immunofluorescence of purified MaxPab antibody to SLC29A2 on HeLa cell. [antibody concentration 10 ug/ml] 50 μL 11 bis 12 Tage
$364.00
Details
Human Kaninchen Unkonjugiert IHC, ELISA, WB 100 μL 2 bis 3 Tage
$446.88
Details
Human Kaninchen Unkonjugiert ELISA, IF, IHC (p), WB   0.1 mg 2 bis 3 Tage
$360.00
Details

Am meisten referenzierte anti-SLC29A2 Antikörper

  1. Human Polyclonal SLC29A2 Primary Antibody für IHC, WB - ABIN2781571 : Owen, Lagpacan, Taylor, De La Cruz, Huang, Kawamoto, Johns, Stryke, Ferrin, Giacomini: Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. in Drug metabolism and disposition: the biological fate of chemicals 2005 (PubMed)
    Show all 2 Pubmed References

  2. Cow (Bovine) Polyclonal SLC29A2 Primary Antibody für WB - ABIN2781572 : Bone, Hammond: Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter. in American journal of physiology. Heart and circulatory physiology 2007 (PubMed)

Weitere Antikörper gegen SLC29A2 Interaktionspartner

Human Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) Interaktionspartner

  1. two novel functional splice variants of equilibrative nucleoside transporter 2 (ENT2), which are present at the nuclear envelope, were identified.

  2. Results showed that both SLC29A1 and SLC29A2 were expressed at lower levels in colon cancer cell lines originating from metastatic sites than from primary sites.

  3. Direct evidence for apical localization of ENT1 and integral expression of ENT2 in intestinal epithelial cells.

  4. these findings reveal the transcriptional repression of ENT1,2 as an innate protective response during acute pulmonary inflammation.

  5. Data suggest that SLC29A2 is localized to apical membrane of adult Sertoli cells. In contrast, SLC29A1 is located on basolateral membrane of Sertoli cells; SLC29A1 is primarily responsible for basolateral nucleoside uptake into Sertoli cells.

  6. Data show that ENT1, ENT2, ENT4 and CNT3 protein was detected on ovarian carcinoma cells in all effusions, with expression observed in 1-95% of tumor cells.

  7. Studies show that ABCC4 and SLC29A2 expression were predictive of achieving CR, and the high expression of GSTP1 suggests that this may be a therapeutic target for relapsed AML.

  8. role in functional and molecular characterization of nucleobase transport

  9. hENT1 and hENT2 on the basolateral membrane function with concentrative nucleoside transporters on the apical membrane to mediate active reabsorption of nucleosides within the kidney.

  10. an analysis of function by site-directed glycosylation mutagenesis

  11. Equilibrative nucleoside transporters (hENT1, hENT2) together with adenosine kinase and 5'-nucleotidase play a crucial role in the regulation of CFTR through an adenosine-dependent pathway in human airway epithelia.

  12. Only a few endometrial carcinomas (15%) were found to be negative for hCNT1, but they all retained hENT1 and hENT2 expression.

  13. residue 33 resides in an extracellular domain as predicted by the current hENT2 topology model and suggested that it is a functionally important component of both the permeant and dipyridamole binding sites.

  14. the corresponding residues in TMs 1 and 11 of hENT1, hENT2, and CeENT1 are important for dipyridamole interactions and nucleoside transport.

  15. The low overall genetic diversity in SLC29A2 makes it unlikely that variation in the coding region contributes significantly to clinically observed differences in drug response.

  16. Data show that insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.

  17. Human cardiac microvascular endothelial cells rely on ENT1 for nucleoside transport with little contribution from ENT2.

  18. These data suggest that selected genes of the SLC28 and SLC29 families are not only targets of HIV-1 infection, but might also contribute to the development of adipose tissue alterations leading to lipodystrophy.

  19. Report expression and hepatobiliary transport characteristics of ENT2 in sandwich-cultured human hepatocytes.

  20. hPMEC from pre-eclampsia exhibit increased total transport (hENT1+hENT2), and maximal velocity (Vmax) for hENT2- (2-fold), but reduced Vmax for hENT1-mediated adenosine transport

Mouse (Murine) Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) Interaktionspartner

  1. Data suggest that crosstalk pathway between ENT2 and alveolar epithelial Adora2b in lung protection during acute lung injury (ALI) opens possibilities for combined therapies targeted to this protein set.

  2. these findings reveal the transcriptional repression of ENT1,2 as an innate protective response during acute pulmonary inflammation.

  3. Inosine and ENT-2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.

  4. HIF-1alpha-dependent repression of ENT2 increases mucosal adenosine signaling and attenuates hypoxia-associated inflammation of the intestine.

Cow (Bovine) Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) Interaktionspartner

  1. Ruminal infusion of starch hydrolysate increased duodenal and ileal expression ENT2 mRNA. Abomasal infusion increased ileal and jejunal ENT2 mRNA expression.

SLC29A2 Antigen-Profil

Protein Überblick

The uptake of nucleosides by transporters, such as SLC29A2, is essential for nucleotide synthesis by salvage pathways in cells that lack de novo biosynthetic pathways. Nucleoside transport also plays a key role in the regulation of many physiologic processes through its effect on adenosine concentration at the cell surface (Griffiths et al., 1997

Genbezeichner und Symbole assoziert mit SLC29A2

  • solute carrier family 29 member 2 (SLC29A2) Antikörper
  • solute carrier family 29 (nucleoside transporters), member 2 (Slc29a2) Antikörper
  • solute carrier family 29 member 2 (Slc29a2) Antikörper
  • solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog (slc29a2.L) Antikörper
  • solute carrier family 29 (equilibrative nucleoside transporter), member 2 (slc29a2) Antikörper
  • der12 Antikörper
  • DKFZp468L038 Antikörper
  • ent2 Antikörper
  • hnp36 Antikörper
  • MGC82995 Antikörper
  • zgc:110527 Antikörper

Bezeichner auf Proteinebene für SLC29A2

36 kDa nucleolar protein HNP36 , delayed-early response protein 12 , equilibrative NBMPR-insensitive nucleoside transporter , equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter , equilibrative nucleoside transporter 2 , hydrophobic nucleolar protein, 36 kDa , hydrophobic nucleolar protein, 36kD , nucleoside transporter, ei-type , solute carrier family 29 (nucleoside transporters), member 2 , solute carrier family 29 member 2 , 36 kDa hydrophobic nucleolar protein , delayed early response gene 12 , solute carrier family 29, member 2 , NBMPR-insensitive nucleoside transporter ei

GENE ID SPEZIES
3177 Homo sapiens
13340 Mus musculus
65194 Rattus norvegicus
444417 Xenopus laevis
451345 Pan troglodytes
531564 Bos taurus
548864 Xenopus (Silurana) tropicalis
611913 Canis lupus familiaris
100009420 Oryctolagus cuniculus
100294577 Pongo abelii
100052412 Equus caballus
100715030 Cavia porcellus
100518596 Sus scrofa
503537 Danio rerio
Ausgewählte Anbieter für anti-SLC29A2 (SLC29A2) Antikörper
Haben Sie etwas anderes gesucht?